Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)
Clinical trial NCT06943235 · RECRUITING
Trial details
- NCT number
- NCT06943235
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-25
- Primary completion
- 2027-04-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.